Physician profile
Alicja Correll
NPI 1215426283
$7,410.42
in general payments reported to CMS, 2019-2025
36 companies · $1,738 in 2025
The $1,738 reported for 2025 was more than what 94% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $37.83 · 2021: $742 · 2022: $1,176 · 2023: $1,782 · 2024: $1,934 · 2025: $1,738.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,445 · Education: $8.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,445.17 |
| Education | $8.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,132.28 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $841.94 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $823.80 | 2021-2025 | |
| Pfizer INC. | $644.79 | 2023-2025 | |
| Abbvie INC. | $535.41 | 2022-2025 | Vraylar, Qulipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $464.38 | 2021-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $315.00 | 2021-2025 | Spravato, Xarelto |
| Astrazeneca Pharmaceuticals LP | $300.98 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Abbott Laboratories | $297.25 | 2022-2025 | Freestyle Libre 3, Diamondback Peripheral, Freestyle Libre 2 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $257.87 | 2023-2024 | Xifaxan |
| Merck Sharp & Dohme LLC | $215.81 | 2020-2024 | Gardasil 9, Vaxneuvance, Vaxelis |
| Glaxosmithkline, LLC. | $162.67 | 2020-2025 | Shingrix, Arexvy, Bexsero |
| Dexcom, INC. | $150.35 | 2024-2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $141.80 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amgen INC. | $137.45 | 2025 | Krystexxa, Repatha, Otezla |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alicja Correll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.